|
GOPC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.171900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.520400E-01 |
| Normal-vs-Stage2 |
4.391200E-01 |
| Normal-vs-Stage3 |
2.244500E-03 |
| Normal-vs-Stage4 |
1.258050E-03 |
| Stage1-vs-Stage2 |
8.481200E-01 |
| Stage1-vs-Stage3 |
1.273930E-02 |
| Stage1-vs-Stage4 |
6.497100E-03 |
| Stage2-vs-Stage3 |
2.914400E-01 |
| Stage2-vs-Stage4 |
2.293000E-01 |
| Stage3-vs-Stage4 |
7.647800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.703830E-02 |
| Normal-vs-AfricanAmerican |
1.165360E-01 |
| Normal-vs-Asian |
1.280800E-01 |
| Caucasian-vs-AfricanAmerican |
9.443800E-01 |
| Caucasian-vs-Asian |
4.603500E-02 |
| AfricanAmerican-vs-Asian |
5.586500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.204130E-02 |
| Normal-vs-Female |
1.713820E-01 |
| Male-vs-Female |
2.445200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.227040E-01 |
| Normal-vs-Age(41-60Yrs) |
2.682200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.080900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.596600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.481000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.878200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.361200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.948100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.693600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.503830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.913600E-02 |
| Normal-vs-Grade 2 |
9.435800E-01 |
| Normal-vs-Grade 3 |
1.381630E-04 |
| Normal-vs-Grade 4 |
2.208700E-04 |
| Grade 1-vs-Grade 2 |
4.746000E-02 |
| Grade 1-vs-Grade 3 |
2.008000E-04 |
| Grade 1-vs-Grade 4 |
6.015800E-04 |
| Grade 2-vs-Grade 3 |
1.93276999999048E-05 |
| Grade 2-vs-Grade 4 |
7.96720000000306E-05 |
| Grade 3-vs-Grade 4 |
2.863800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.129400E-01 |
| Normal-vs-ccB subtype |
2.117900E-03 |
| ccA subtype-vs-ccB subtype |
1.239070E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.154560E-01 |
| Normal-vs-N1 |
1.836220E-03 |
| N0-vs-N1 |
4.291900E-02 |
|
|
